SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3336Predicable result, IMO: siliconinvestor.comDewDiligence_on_SI-3/24/2016
3335Portola Pharmaceuticals Announces Topline Results from Phase 3 APEX Trial of BetJulius Wong-3/24/2016
3334FDA rejects Eagle Pharma's New Drug Application for anticoagulant IV bivalirJulius Wong-3/18/2016
3333Celldex discontinues late-stage study of brain cancer vaccine March 7 (Reuters) Julius Wong-3/7/2016
3332VTAE down premarket.Julius Wong-3/4/2016
3331PTCT, after getting an RTF here, then a price cut on its drug in Germany, gets atuck-3/1/2016
3330ENDP was down 21.02% on a volume of 22,334,276 about 6x its ADV.<g> But trJibacoa-2/29/2016
3329CARA continues its slump. Down another 33% in PreMarket trading.<g> elite.Jibacoa-2/26/2016
3328Cara Therapeutics Provides Update on CLIN3001 Postoperative Pain Trial for I.V. Julius Wong-2/25/2016
3327CARA about 50% in AH on clinical holdhmpa-2/25/2016
3326PTCT down >40 % PTC Receives Refuse to File Letter from FDA for Translarna(sjemmeri-2/23/2016
3325No thoughts. Don't follow HALO. If they have a program in similar indicatituck-2/11/2016
3324HALO seems to be up on INCY's poor pancreatic cancer trial. (Horrible diseasPravda-2/11/2016
3323Incyte (INCY) off 19% on discontinuation of all trials of Jakafi in solid tumorstuck-2/11/2016
3322EDIT -19%—this article may be part of the reason: technologyreview.comDewDiligence_on_SI-2/9/2016
3321As of Friday’s close, just 9 of the 224 portfolio stocks are up for the year. MThe Ox-2/8/2016
3320BioCryst Angioedema Drug Fails in Midstage StudyJulius Wong-2/8/2016
3319Alkermes down 30% PM.Julius Wong-1/21/2016
3318Alkermes depression drug fails in two late-stage studies finance.yahoo.comJulius Wong-1/21/2016
3317EBIO -68% on Friday evening's news: siliconinvestor.comDewDiligence_on_SI-1/19/2016
3316PTCT almost 20 % - guilt by association?sjemmeri-1/15/2016
3315SRPT -43%/PM on FDA posting of briefing docs for 1/22/16 panel meeting: t.coDewDiligence_on_SI-1/15/2016
3314Re: Biotechs trading for <cash There’s a board for that, but the most recenDewDiligence_on_SI-1/13/2016
3313Its on the Pharma list. Years back someone rkrw? posted a list of Bio's at/ghmm-1/13/2016
3312Not sure why it didn't show up....found at the 52 week Nasdaq lows here: stoThe Ox-1/13/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News